Evaluation of a newly developed rapid automated fluorescent lateral flow immunoassay to detect igg and igm antibodies to chikungunya virus

2Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The ichroma Chikungunya virus (CHIKV) IgG/IgM (Boditech Med Inc., Chuncheon, Korea) is a newly developed rapid lateral flow immunoassay for detection of anti- CHIKV-IgG/ IgM. This study conducted with thirty-six anti-CHIKV IgG positive sera, 57 anti-CHIKV IgM positive sera and 163 anti-CHIKV IgG/IgM negative sera which were confirmed by commercial enzyme-linked immunosorbent assays (ELISAs) (Inbios CHIKjj Detect™ IgM Capture ELISA, Inbios CHIKjj Detect™ IgG ELISA (InBios International Inc., Seattle, WA, USA), Anti-CHIKV ELISA (IgM), Anti- CHIKV ELISA (IgG) (Euroimmun, Lübeck, Germany)). The ichroma detected all 36 anti-CHIKV IgG and 57 anti-CHIKV IgM positivity (100% sensitivity). For 163 anti-CHIKV IgG/IgM negative sera, the ichroma showed one false positive for IgM (99.4% specificity). The ichroma showed no cross-reactivity and no interference. The ichroma demonstrated good diagnostic performance compared to the current ELISAs.

Cite

CITATION STYLE

APA

Lee, H., Ryu, J. H., Yun, S., Jang, J. H., Choi, A. R., Cho, S. Y., … Oh, E. J. (2020). Evaluation of a newly developed rapid automated fluorescent lateral flow immunoassay to detect igg and igm antibodies to chikungunya virus. Infection and Chemotherapy, 52(4), 611–615. https://doi.org/10.3947/IC.2020.52.4.611

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free